Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Retatrutide, an investigational triple GIP/GLP-1/glucagon receptor agonist developed by Eli Lilly, demonstrated unprecedented weight loss in Phase 2 trials but has not yet completed Phase 3 development
The biggest cost drivers are prescription pricing, lab repetition, and extra follow-ups during dose titration, so a low advertised rate can rise quickly once add-ons and testing are included
Cardiovascular Health: Several GLP-1 agonists have been shown to reduce the risk of heart disease, supporting long-term vitality
Disclosure quality: Whether platforms distinguish between FDA-approved branded medications and compounded formulations
Strengths: Estriol 0.3% Niacinamide 3% GHK-Cu 0.2% Hyaluronic Acid 0.5% Supports: Skin Density Hydration Firmness Barrier Repair Hormonal Skin Changes Starting at $65 per month* A prescription-strength retinoid designed to accelerate skin turnover, refine texture, and improve the appearance of fine lines and uneven tone
/assets/images/provider/photos/2800172.png)
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 26.72
US$ 25.98
US$ 26.03
